Albert Schomig, MD
Deutsches Herzzentrum Muenchen
9
0
8
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+4 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (9)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Franz-Josef Neumann, MD
Herz-zentrum Bad Krozingen
Shared therapeutic areas:
Worked with same sponsors:
Ilka Ott, MD
Deutsches Herzzentrum Muenchen
Shared therapeutic areas:
Worked with same sponsors:
Harry Hemingway, FRCP
University College, London
Shared therapeutic areas:
Peter B Berger, MD
Duke Clinical Research Institute
Shared therapeutic areas:
Worked with same sponsors:
Hyo-soo Kim, MD, PhD
Seoul National University Hospital
Shared therapeutic areas:
Bon-Kwon Koo, MD, PhD
Seoul National University Hospital
Shared therapeutic areas:
Nicolas von Beckerath, MD
Deutsches Herzzentrum Muenchen
Shared therapeutic areas:
Worked with same sponsors:
Kurt Huber, MD
Wilhelminenspital der Stadt Wien
Shared therapeutic areas:
Worked with same sponsors:
Amir Lerman, MD
Mayo Clinic
Shared therapeutic areas:
Ron Waksman, MD
Medstar Health Research Institute
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (9)
Showing 9 of 9 trials
Bone Marrow Stem Cell Mobilisation Therapy for Acute Myocardial Infarction (AMI)(REVIVAL-2)
Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2)
Value of Abciximab in Patients With AMI Undergoing Primary PCI After Clopidogrel Pretreatment (BRAVE 3)
75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)
Nonpolymer- and Polymer-Based Drug-Eluting Stents for Restenosis (ISAR-TEST-1)
Sirolimus- and Paclitaxel-Eluting Stents for Small Vessels (ISAR-SMART-3)
Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis
Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3)
Efficacy Study of Erythropoietin After Revascularization in Myocardial Infarction (REVIVAL-3)
All 9 trials loaded